# Body-Wide Glycolytic Shift, Oxidative Stress, and Sex-Specific Effect of Caloric Restriction in a Mouse Model of Alzheimer’s Disease

**Authors:** Myroslava V. Vatashchuk, Viktoriia V. Hurza, Kuang Pan, Maria M. Bayliak, Dmytro V. Gospodaryov, Volodymyr I. Lushchak, Olga Garaschuk

PMC · DOI: 10.3390/antiox15020191 · Antioxidants · 2026-02-02

## TL;DR

This study explores how Alzheimer’s disease affects metabolism and oxidative stress in different organs and how caloric restriction impacts these effects differently in male and female mice.

## Contribution

The study reveals sex-specific metabolic and oxidative changes in Alzheimer’s disease and how caloric restriction modulates these effects in a tissue-specific manner.

## Key findings

- APPPS1 mice showed increased oxidative stress and altered glycolytic enzyme activity in brain, liver, and kidney compared to wild-type mice.
- Caloric restriction had sex-specific effects, intensifying lipid peroxide accumulation in some organs while reducing it in others.
- CR potentiated glycolysis and modulated glutathione-dependent enzymes in a sex-dependent manner.

## Abstract

Alzheimer’s disease (AD) is regarded as a disease of the brain. Cumulative evidence increasingly supports a full-body view on this disorder, with the liver and kidneys playing an important role in amyloid clearance. The latter is likely potentiated by caloric restriction (CR), whose impact on the metabolism of amyloid-handling tissues is poorly understood. We studied the sex-specific effects of amyloidosis and CR on oxidative and metabolic processes in APPPS1 mice that express amyloidogenic proteins. Wild-type (WT) and APPPS1 mice were either fed ad libitum (AL) or received 70% of their AL caloric intake (CR). Compared to age-matched WT controls, the brain, liver, and kidney of 9-month-old AL APPPS1 mice exhibited higher levels of oxidative stress markers, higher superoxide dismutase, and lower catalase activities. These differences were sex- and tissue-specific, with kidneys showing the largest AD-induced differences between sexes. In addition, APPPS1 mice possessed higher pyruvate kinase activity than WT mice in all organs and higher hexokinase and phosphofructokinase activities in the brain, with stronger effects in males. CR intensified the accumulation of lipid peroxides in the liver and the female brain but decreased it in the female kidney. CR potentiated glycolysis, predominantly in females and modulated glutathione-dependent enzymes, in a sex-dependent manner.

## Linked entities

- **Proteins:** APP (amyloid beta precursor protein), PSEN1 (presenilin 1)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** TAS2R64P (taste 2 receptor member 64, pseudogene) [NCBI Gene 338412] {aka PS2, T2R64, T2R64P}, Pphln1 (periphilin 1) [NCBI Gene 223828] {aka CR, HSPC206, HSPC232}, Sirt3 (sirtuin 3) [NCBI Gene 64384] {aka 2310003L23Rik, Sir2l3}, Pklr (pyruvate kinase liver and red blood cell) [NCBI Gene 18770] {aka Pk-1, Pk1, R-PK}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Thy1 (thymus cell antigen 1, theta) [NCBI Gene 21838] {aka CD90, T25, Thy-1, Thy-1.2, Thy1.1, Thy1.2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Syp (synaptophysin) [NCBI Gene 20977] {aka A230093K24Rik, Syn, p38}, Prdx6-ps2 (peroxiredoxin 6 pseudogene 2) [NCBI Gene 384001] {aka Aop2-rs2, GPx*, Prdx6-rs2}, Hpgds (hematopoietic prostaglandin D synthase) [NCBI Gene 54486] {aka H-PGDS, Ptgds2}, Spag5 (sperm associated antigen 5) [NCBI Gene 54141] {aka D11Bhm180e, Deepest, MAP126, Mastrin, S17}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Gsr (glutathione reductase) [NCBI Gene 14782] {aka D8Ertd238e, Gr-1, Gr1}, Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Chst7 (carbohydrate sulfotransferase 7) [NCBI Gene 60322] {aka 2600013M07Rik, C6ST-2, GST5, Gn6st-4, glcNAc6ST-4}, Tpi1 (triosephosphate isomerase 1) [NCBI Gene 21991] {aka TIM, Tpi, Tpi-1}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, Ms6hm3 (minisatellite 6 hypermutable 3) [NCBI Gene 111469] {aka PC-2}, Cybb (cytochrome b-245, beta polypeptide) [NCBI Gene 13058] {aka CGD91-phox, Cgd, Cyd, Nox2, gp91-1, gp91phox}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}
- **Diseases:** impaired lipid (MESH:D011017), CR (MESH:D002313), cognitive decline (MESH:D003072), memory loss (MESH:D008569), type 2 diabetes (MESH:D003924), neuronal death (MESH:D009410), amyloidosis (MESH:D000686), amyloid (MESH:C000718787), neuronal hyperactivity (MESH:D001289), weight loss (MESH:D015431), cerebrovascular dysfunction (MESH:D002561), insulin resistance (MESH:D007333), death (MESH:D003643), impairment of energy metabolism (MESH:D008659), hyperactivity of neural networks (MESH:D006948), cerebral amyloidosis (MESH:C538248), neurofibrillary (MESH:D055956), Obesity (MESH:D009765), Neurotoxic (MESH:D020258), AD (MESH:D000544), lysosomal (MESH:D016464), anxiety (MESH:D001007), neuroinflammation (MESH:D000090862), inflammation (MESH:D007249), injury to (MESH:D014947), neurodegeneration (MESH:D019636), hyperglycemia (MESH:D006943), mitochondrial dysfunction (MESH:D028361)
- **Chemicals:** NAD+ (MESH:D009243), KCl (MESH:D011189), cellulose (MESH:D002482), dihydroxyacetone phosphate (MESH:D004099), Cumene hydroperoxide (MESH:C007164), glucose (MESH:D005947), ROS (MESH:D017382), 1-chloro-2,4-dinitrobenzene (MESH:D004137), ATP (MESH:D000255), peroxynitrite (MESH:D030421), N,N,N',N'-tetramethylethylenediamine (MESH:C005798), GSH (MESH:D005978), lipid (MESH:D008055), phenylmethylsulfonyl fluoride (MESH:D010664), peroxides (MESH:D010545), heme (MESH:D006418), NADP+ (MESH:D009249), GSSG (MESH:D019803), trichloroacetic acid (MESH:D014238), succinyl-CoA (MESH:C012046), carbohydrate (MESH:D002241), acrolein (MESH:D000171), H2O2 (MESH:D006861), superoxide (MESH:D013481), AL (-), trioses (MESH:D014306), fructose 6-phosphate (MESH:C027618), dithiothreitol (MESH:D004229), xylenol orange (MESH:C016833), 4-HNE (MESH:C027576), nitric oxide (MESH:D009569), ethanol (MESH:D000431), hydroxyl (MESH:D017665), glycine (MESH:D005998), blood glucose (MESH:D001786), imidazole (MESH:C029899), water (MESH:D014867), phospholipid (MESH:D010743), glycerol-3-phosphate (MESH:C029620), sodium azide (MESH:D019810), PEP (MESH:D010728), thiobarbiturate (MESH:C029684), NaF (MESH:D012969), Thioflavin S (MESH:C009462), lactate (MESH:D019344), 6-phosphogluconolactone (MESH:C114004), potassium phosphate (MESH:C013216), quercetin (MESH:D011794), xylazine (MESH:D014991), G6P (MESH:D019298), ADP (MESH:D000244), LOOH (MESH:D008054), pyruvate (MESH:D019289), MgCl2 (MESH:D015636), 2,4-dinitrophenylhydrazine (MESH:C004787), oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606], Macaca mulatta (rhesus macaque, species) [taxon 9544], Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932]
- **Mutations:** L166P, V717F
- **Cell lines:** C57BL/6N — Mus musculus (Mouse), Embryonic stem cell (CVCL_2H81)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937841/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937841/full.md

## References

93 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937841/full.md

---
Source: https://tomesphere.com/paper/PMC12937841